In adult patients with nondysplastic Barrett esophagus at last endoscopy, a subsequent capsule-sponge test can assist in ...

CapsoVision announced today that it closed its initial public offering (IPO) and began trading on the Nasdaq Capital Market.

HealthDay News — In adult patients with nondysplastic Barrett esophagus at last endoscopy, a subsequent capsule-sponge test can assist in identifying those at highest risk of dysplasia or cancer ...

A new, far less invasive capsule sponge test to detect early cancer signs could safely replace the use of regular endoscopies ...

Endoscopies could be replaced by far less invasive capsule sponge tests for half of all patients with Barrett's esophagus, a ...

“Our findings suggest that the capsule sponge could help stratify patients with Barrett’s esophagus by risk and that half of ...

Learn about the "pill-on-a-thread" that could replace endoscopies for half of all patients at risk of developing esophageal ...

Endoscopies could be replaced by far less invasive capsule sponge tests for half of all patients with Barrett's esophagus, a ...

The ‘pill-on-a-thread’ test invented in Cambridge could be used as a far less invasive alternative to endoscopies for half of ...

Given that the risk of these individuals progressing to dysplasia and then to esophageal cancer is so low, it should be safe to replace their usual endoscopy with the capsule sponge." ...